AI filing briefs · archive

8-K filings in March 2026, explained

815 material Form 8-K filings that 659 companies we cover made with the SEC in March 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

2 of 815 briefs match

newest first · times in ET
STROSUTRO BIOPHARMA, INC. Mar 23, 4:32 PM ET

Sutro Biopharma reports 2025 revenue of $102.5 million, net loss of $191.1 million

Mixed earnings Written later 1.022.02

Sutro Biopharma reported full-year 2025 results in a press release furnished with an 8-K on March 23, 2026. Revenue rose to $102.5 million from $62.0 million and net loss narrowed to $191.1 million from $227.5 million, but the company also recorded $53.4 million in restructuring and related costs. The company also terminated its at-the-market share sales agreement with Jefferies LLC effective March 23, 2026, so it can no longer sell common shares under that program.

  • Revenue was $102.5 million for 2025, up from $62.0 million in 2024, mainly tied to Astellas and Ipsen collaborations.
  • Net loss was $191.1 million, or $22.49 per share, versus $227.5 million, or $29.40 per share, in 2024.
  • Restructuring and related costs were $53.4 million in 2025, compared with none in 2024.
  • Cash, cash equivalents and marketable securities were $141.4 million at December 31, 2025, versus $316.9 million a year earlier.
Read the filing on SEC.gov ↗
CDECoeur Mining, Inc. Mar 23, 7:00 AM ET

Coeur completes New Gold acquisition, issues about 393 million shares

Mixed m&a Written later 1.012.013.023.035.025.037.018.01

Coeur Mining completed its acquisition of New Gold on March 20, 2026, issuing about 393 million Coeur common shares to New Gold shareholders and entering a new $1.0 billion revolving credit facility. The company also announced an expanded $750 million share repurchase program, an inaugural $0.02 per share semiannual dividend policy, and consolidated 2026 guidance that includes nine months of New Afton and Rainy River production, which means the larger share count and capital return plans both affect shareholders.

  • The arrangement closed on March 20, 2026; each New Gold share was exchanged for 0.4959 Coeur shares, and about 393 million Coeur shares were issued.
  • Authorized Coeur common stock was increased from 900 million to 1.3 billion shares effective March 19, 2026.
  • The $750 million repurchase program replaces the prior $75 million program; the first $0.02 per share dividend is expected in the second quarter of 2026.
  • 2026 consolidated gold production guidance is 680,000 to 815,000 ounces, with nine months of contribution from New Afton and Rainy River.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.